Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy

Journal of Surgical Oncology

Volumn 91, Issue 4, 2005, Pages 237-242

  Ohta, Yasuhiko ^a   Shimizu, Yosuke ^a   Matsumoto, Isao ^a   Tamura, Masaya ^a   Oda, Makoto ^a   Watanabe, Go ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinomatous pleuritis; Lung cancer; Malignant effusion; Pleurectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOXORUBICIN; GEMCITABINE; NAVELBINE; PACLITAXEL; PICIBANIL; VINDESINE;

ADULT; AGED; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; MALE; PLEURA EFFUSION; PLEURECTOMY; PLEURISY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; PLEURA; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 24644507578     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20333     Document Type: Review

References (20)

1. Reshad K, Inui K, Takeuchi Y, et al.: Treatment of malignant pleural effusion. Chest 1985;88:393-397.
2. Ruckdeschel JC, Moores D, Lee JY, et al.: Intrapleural therapy for malignant pleural effusions: A randomized comparison of bleomycin and tetracycline. Chest 1991;100:1528-1535.
3. Luh KT, Yang PC, Kuo SH, et al.: Comparison of OK-432 and mitomycin C pleudesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992;69:674-679.
4. Kellrer SM: Current and future therapy for malignant pleural effusion. Chest 1993;103:63S-67S.
5. Ostrowski MJ: An assessment of the long term results of controlling the reaccumulation of malignant effusions using intracavitary bleomycin. Cancer 1986;57:721-727.
6. Shimizu J, Oda M, Morita K, et al.: Comparison of pleuropneumonectomy and limited surgery for lung cancer with pleural dissemination. J Surg Oncol 1996;61:1-6.
7. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
8. Ohta Y, Tanaka Y, Hara T, et al.: Clinicopathological and biological assessment of lung cancers with pleural dissemination. Ann Thorac Surg 2000;69:1025-1029.
9. Sawabata N, Matsumura A, Motohiro A, et al.: Malignant minor pleural effusion detected on thoracotomy for patients with nonsmall cell lung cancer: Is tumor resection beneficial for prognosis? Ann Thorac Surg 2002;73:412-415.
10. Bernard A, de Dompsure RB, Hagry O, et al.: Early and late mortality after pleurodosis for malignant pleural effusion. Ann Thorac Surg 2002;74:213-217.
11. Frank A, Baciewicz FA, Jr.: Malignant pleural effusion. In: Pass HI, Mitchell J, Johnson DH, Turrisi AT, Minna JD, editors. Lung cancer principles and practice. Philadelphia: Lippincott Williams & Wilkins; 2000; pp 1027-1037.
12. Nahid P, Broaddus VC: Liquid and protein exchange. In: Light RW, Lee YCG, editors. Textbook of pleural disease. London: Arnold; 2003; pp 35-44.
13. Zebrowski BK, Yano S, Liu W, et al.: Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 1999;5:3364-3368.
14. Thickett DR, Armstrong L, Millar AB: Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 1999;54:707-710.
15. Ohta Y, Kimura K, Tamura M, et al.: Biological characteristics of carcinomatosa pleuritis in orthotopic model systems using immune-deficient rats. Int J Oncol 2001;18:499-505.
16. Martini N, Bains MS, Beattle EJ, Jr.: Indications for pleurectomy in malignant effusion. Cancer 1975;35:734-738.
17. Jensik R, Cagle JE, Jr., Milloy F, et al.: Pleurectomy in the treatment of pleural effusion due to metastatic malignancy. J Thorac Cardiovasc Surg 1963;46:322-330.
18. Harvey JC, Erdman CB, Beattie EJ: Early experience with videothoracoscopic hydrodissection pleurectomy in the treatment of malignant pleural effusion. J Surg Oncol 1995;59:243-245.
19. Perng R-P, Wu M-F, Lin S-H, et al.: A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anticancer Drugs 1997;8:563-573.
20. Perng R-P, Chen Y-M, Wu M-F, et al.: Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respir Med 1998;92:473-479.